Fig. 1 | Nature Communications

Fig. 1

From: Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

Fig. 1

The five selected metabolites for the discrimination of the different CKD stages. a–e Boxplots showed the relative intensities of the five metabolites in serum (left y-axis) and urine (right y-axis) including 5-MTP, CSA, acetylcarnitine, tiglylcarnitine and taurine across all five CKD stages. f, g The levels of serum CREA and urea across all five CKD stages. h The levels of proteinuria across all five CKD stages. Dot plot and line showed the relative intensities of the five urinary metabolites including 5-MTP, CSA, acetylcarnitine, tiglylcarnitine and taurine across all five CKD stages. In the boxplot, the median is represented by the center line, 75 percentile is represented by the upper bound of the box, 25 percentile is represented by the lower bound of the box, minimum is represented by the lower whisker, and maximum is represented by the upper whisker

Back to article page